Know Cancer

or
forgot password

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life


N/A
18 Years
N/A
Open (Enrolling)
Both
Retinoblastoma

Thank you

Trial Information

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life


Inclusion Criteria:



- Patient diagnosed with retinoblastoma at any age

- At least 18 years at the time of study enrollment

- Able to provide informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

To describe the long-term health status of adult survivors of childhood retinoblastoma, General medical outcomes, vision status, Rates of second cancer

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Ira Dunkel, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

08-019

NCT ID:

NCT00639301

Start Date:

March 2008

Completion Date:

March 2014

Related Keywords:

  • Retinoblastoma
  • Survivor
  • Quality of Life
  • Eye
  • Retinoblastoma

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021